Skip to main content

PATOLOGIA MOLECULAR DE LA DEFICIENCIA DE ANTITROMBINA: DESARROLLO DE NUEVOS METODOS DIAGNOSTICOS E IMPLICACIONES CLINICAS.

PI18/00598

•
Funding agency name Instituto de Salud Carlos III
Funding agency acronym ISCIII
Program Programa Estatal de Fomento de la Investigación Científica y Técnica de Excelencia
Subprogram Subprograma Estatal de Generación de Conocimiento
Call Proyectos de Investigación en Salud
Call year 2018
State Plan 2013-2016 Plan Estatal de Investigación Científica y Técnica y de Innovación
Beneficiary centre FUNDACION PARA LA FORMACION E INVESTIGACION SANITARIAS DE LA REGION DE MURCIA (FFIS)
Execution centre INSTITUTO MURCIANO DE INVESTIGACION BIOSANITARIA (IMIB)

Resultados relacionados

Resultados totales (Incluyendo duplicados): 1
Encontrada(s) 1 página(s)

Dipòsit Digital de Documents de la UAB
Publication Artículo científico (JournalArticle)

Long-Read Sequencing Identifies the First Retrotransposon Insertion and Resolves Structural Variants Causing Antithrombin Deficiency

  • De La Morena-Barrio, Belén|||0000-0002-6696-7762
  • Stephens, J.
  • De La Morena-Barrio, M.E.|||0000-0001-7426-4947
  • Stefanucci, L.
  • Padilla, J.
  • Miñano, A.
  • Gleadall, N.
  • García, J.L.
  • López-Fernández, M.F.
  • Morange, Pierre-Emmanuel|||0000-0002-9065-722X
  • Puurunen, M.
  • Undas, A.
  • Vidal, Francisco|||0000-0001-8089-4945
  • Raymond, F.L.
  • Vicente, V.
  • Ouwehand, W.H.
  • Corral, J.
  • Sanchis-Juan, A.
The identification of inherited antithrombin deficiency (ATD) is critical to prevent potentially life-threatening thrombotic events. Causal variants in SERPINC1 are identified for up to 70% of cases, the majority being single-nucleotide variants and indels. The detection and characterization of structural variants (SVs) in ATD remain challenging due to the high number of repetitive elements in SERPINC1. Here, we performed long-read whole-genome sequencing on 10 familial and 9 singleton cases with type I ATD proven by functional and antigen assays, who were selected from a cohort of 340 patients with this rare disorder because genetic analyses were either negative, ambiguous, or not fully characterized. We developed an analysis workflow to identify disease-associated SVs. This approach resolved, independently of its size or type, all eight SVs detected by multiple ligation-dependent probe amplification, and identified for the first time a complex rearrangement previously misclassified as a deletion. Remarkably, we identified the mechanism explaining ATD in 2 out of 11 cases with previous unknown defect: the insertion of a novel 2.4 kb SINE-VNTR-Alu retroelement, which was characterized by de novo assembly and verified by specific polymerase chain reaction amplification and sequencing in the probands and affected relatives. The nucleotide-level resolution achieved for all SVs allowed breakpoint analysis, which revealed repetitive elements and microhomologies supporting a common replication-based mechanism for all the SVs. Our study underscores the utility of long-read sequencing technology as a complementary method to identify, characterize, and unveil the molecular mechanism of disease-causing SVs involved in ATD, and enlarges the catalogue of genetic disorders caused by retrotransposon insertions.